InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Thomas John Charles. Officer active across 1 company, notably Krystal Biotech, Inc.. Cumulatively, 1 reports have been recorded. Activity tracked since 25 June 2026. The latest transaction was disclosed on 25 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条